| 发明名称 |
ANTIANGIOGENIC COMBINATION THERAPY FOR THE TREATMENT OF CANCER. |
| 摘要 |
<p>The present invention provides combinations of a DNA topoisomerase I inhibiting agent and a selective COX-2 inhibiting agent for preventing, treating, and/or reducing the risk of developing a neoplasia disorder in a mammal.</p> |
| 申请公布号 |
MXPA03009886(A) |
申请公布日期 |
2004.11.22 |
| 申请号 |
MX2003PA09886 |
申请日期 |
2002.04.25 |
| 申请人 |
PHARMACIA CORPORATION |
发明人 |
STEPHEN T. GATELY |
| 分类号 |
A61K31/00;A61K31/135;A61K31/277;A61K31/353;A61K31/365;A61K31/382;A61K31/415;A61K31/42;A61K31/444;A61K31/445;A61K31/454;A61K31/47;A61K31/473;A61K31/4745;A61K31/505;A61K31/506;A61K31/5685;A61K31/675;A61K31/7056;A61K31/7064;A61K33/24;A61K41/00;A61K45/06;A61P9/00;A61P13/08;A61P13/10;A61P35/00;A61P43/00;(IPC1-7):A61K45/06 |
主分类号 |
A61K31/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
